Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Treatment of Restless Legs Syndrome With Suvorexant
2017-004580-12Phase 2Active
- Sponsor
- Instituto de Investigaciones del Sueño
- Start
- Jan 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2 trial of suvorexant in restless legs syndrome (RLS) and Insomnia, sponsored by Instituto de Investigaciones del Sueño. Started Jan 2018; status: active.
02
Drugs
suvorexant
03
Conditions
restless legs syndrome (RLS)Insomnia
Beyond the preview
Go deeper on 2017-004580-12.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2017-004580-12.